• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

利伐沙班在急性冠状动脉综合征中的应用：我们有指南针和地图，但我们要往哪里走？

Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed?

机构信息

1 Division of Cardiology Department of Medicine and Duke Clinical Research Institute Duke University Medical Center Durham NC.

出版信息

J Am Heart Assoc. 2019 Mar 5;8(5):e012014. doi: 10.1161/JAHA.119.012014.

DOI:10.1161/JAHA.119.012014
PMID:30813822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6474921/
Abstract

See Article by Gibson et al.

摘要

见 Gibson 等人的文章。

相似文献

1
Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed?利伐沙班在急性冠状动脉综合征中的应用：我们有指南针和地图，但我们要往哪里走？
J Am Heart Assoc. 2019 Mar 5;8(5):e012014. doi: 10.1161/JAHA.119.012014.
2
Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51.在 ATLAS-ACS 2 TIMI 51 研究中，接受利伐沙班治疗的急性冠脉综合征患者中支架血栓形成减少。
J Am Coll Cardiol. 2013 Jul 23;62(4):286-90. doi: 10.1016/j.jacc.2013.03.041. Epub 2013 Apr 16.
3
Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome.抗 Xa 治疗降低急性冠状动脉综合征患者心血管事件的作用及标准治疗的附加作用（血栓溶解治疗急性心肌梗死 51 研究）的研究原理和设计：一项评估利伐沙班在急性冠状动脉综合征患者中的疗效和安全性的随机、双盲、安慰剂对照研究。
Am Heart J. 2011 May;161(5):815-821.e6. doi: 10.1016/j.ahj.2011.01.026.
4
The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.利伐沙班在心房颤动和急性冠状动脉综合征中的作用。
J Cardiovasc Pharmacol Ther. 2014 Nov;19(6):526-32. doi: 10.1177/1074248414525505. Epub 2014 Mar 21.
5
Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial.生物标志物阳性患者急性冠脉综合征后应用利伐沙班进行二级预防的安全性和疗效：来自 ATLAS ACS 2-TIMI 51 试验的结果。
Eur Heart J Acute Cardiovasc Care. 2019 Mar;8(2):186-193. doi: 10.1177/2048872617745003. Epub 2017 Dec 18.
6
Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2-TIMI 51).两种剂量利伐沙班治疗急性冠状动脉综合征（来自 ATLAS ACS 2-TIMI 51）的疗效和安全性比较。
Am J Cardiol. 2013 Aug 15;112(4):472-8. doi: 10.1016/j.amjcard.2013.04.011. Epub 2013 May 24.
7
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.在急性冠脉综合征（GEMINI-ACS-1）中，与低剂量利伐沙班加 P2Y12 抑制相比，加用阿司匹林导致临床显著出血：一项双盲、多中心、随机试验。
Lancet. 2017 May 6;389(10081):1799-1808. doi: 10.1016/S0140-6736(17)30751-1. Epub 2017 Mar 18.
8
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.利伐沙班与安慰剂用于急性冠脉综合征患者的疗效对比（ATLAS ACS-TIMI 46）：一项随机、双盲、II期试验
Lancet. 2009 Jul 4;374(9683):29-38. doi: 10.1016/S0140-6736(09)60738-8. Epub 2009 Jun 17.
9
Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51).利伐沙班治疗 ST 段抬高型心肌梗死患者稳定后的疗效：来自 ATLAS ACS-2-TIMI-51 试验的结果（抗 Xa 治疗联合标准治疗降低急性冠脉综合征患者心血管事件的发生率-心肌梗死溶栓治疗-51）。
J Am Coll Cardiol. 2013 May 7;61(18):1853-9. doi: 10.1016/j.jacc.2013.01.066. Epub 2013 Mar 7.
10
Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.利伐沙班、阿司匹林或两者联合预防早期冠状动脉旁路移植术闭塞：COMPASS-CABG 研究。
J Am Coll Cardiol. 2019 Jan 22;73(2):121-130. doi: 10.1016/j.jacc.2018.10.048.

引用本文的文献

1
The efficacy and safety of direct oral anticoagulants plus aspirin in symptomatic lower extremity peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials.直接口服抗凝剂联合阿司匹林治疗有症状的下肢外周动脉疾病的疗效和安全性：系统评价和随机对照试验的荟萃分析。
J Thromb Thrombolysis. 2021 Oct;52(3):904-913. doi: 10.1007/s11239-021-02417-3. Epub 2021 Mar 11.

本文引用的文献

1
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.利伐沙班联合或不联合阿司匹林用于稳定型心血管疾病。
N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27.
2
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228. doi: 10.1016/j.jacc.2014.09.017. Epub 2014 Sep 23.
3
National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999-2010.1999 - 2010年医疗保险受益人群急性心肌梗死后1年复发性急性心肌梗死住院治疗的全国趋势
J Am Heart Assoc. 2014 Sep 23;3(5):e001197. doi: 10.1161/JAHA.114.001197.
4
Antiplatelet and anticoagulation therapy for acute coronary syndromes.急性冠脉综合征的抗血小板和抗凝治疗。
Circ Res. 2014 Jun 6;114(12):1929-43. doi: 10.1161/CIRCRESAHA.114.302737.
5
Rivaroxaban in patients with a recent acute coronary syndrome.利伐沙班用于近期急性冠状动脉综合征患者。
N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.
6
Apixaban with antiplatelet therapy after acute coronary syndrome.急性冠脉综合征后应用阿哌沙班联合抗血小板治疗。
N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819. Epub 2011 Jul 24.
7
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.稳定性动脉粥样硬化血栓形成高危或患者 4 年心血管事件发生率的比较决定因素。
JAMA. 2010 Sep 22;304(12):1350-7. doi: 10.1001/jama.2010.1322. Epub 2010 Aug 30.
8
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.替格瑞洛与氯吡格雷用于急性冠脉综合征患者的比较
N Engl J Med. 2009 Sep 10;361(11):1045-57. doi: 10.1056/NEJMoa0904327. Epub 2009 Aug 30.
9
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.急性冠状动脉综合征后阿司匹林联合华法林与单用阿司匹林的比较：对25307例患者的更新全面荟萃分析
Eur Heart J. 2006 Mar;27(5):519-26. doi: 10.1093/eurheartj/ehi485. Epub 2005 Sep 5.